Type 2 diabetes trials focus on achieving durable glycemic control while reducing cardiovascular mortality, kidney disease progression, and body weight — goals now achievable with newer drug classes that were unavailable a decade ago. The success of GLP-1 receptor agonists and SGLT2 inhibitors in cardiovascular outcome trials has reshaped trial design toward hard endpoint studies.
Active research areas include novel GLP-1 analogs with improved dosing profiles, combination GLP-1/GIP/glucagon triagonists, once-weekly oral formulations, bariatric surgery comparisons, and precision medicine approaches to match patients to optimal drug classes based on genetics, microbiome, or biomarkers.
Trials typically require a confirmed type 2 diagnosis with HbA1c in a specified range; cardiovascular outcome trials often require existing heart disease or high cardiovascular risk.
Frequently Asked Questions — type 2 diabetes Clinical Trials
How many clinical trials are currently recruiting for type 2 diabetes?
ClinicalMetric currently tracks 1 actively recruiting clinical trials for type 2 diabetes, sourced in real time from ClinicalTrials.gov. The total number of registered studies—including those not yet enrolling or in active follow-up—is 1. Trial availability changes daily as new studies open enrollment and existing ones reach capacity.
What trial phases are available for type 2 diabetes?
type 2 diabetes research spans Phase 4 (1 trial). Phase 1 studies evaluate safety and dosing in small groups, Phase 2 studies assess preliminary efficacy in 100–300 participants, and Phase 3 trials compare the new treatment against the standard of care in 300–3,000+ patients. Phase 4 post-approval studies monitor long-term outcomes in real-world populations.
How do I find out if I qualify for a type 2 diabetes clinical trial?
Eligibility criteria for type 2 diabetes trials vary by study and typically specify age range, disease stage or severity, prior treatment history, and specific diagnostic or laboratory parameters. Each listing on ClinicalMetric links to the full protocol on ClinicalTrials.gov, where inclusion and exclusion criteria are documented. Contact the sponsoring site's research coordinator directly to confirm your eligibility—your treating physician or specialist can also help identify the most appropriate trial based on your medical history and current treatment status.
Top Sponsors
China National Center for Cardiovascular Diseases 1 trial
Recruiting Clinical Trials
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional.
Full Disclaimer ·
Last Reviewed: April 2026 ·
Data Methodology